AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges... Nov 21
VFMCRP and Fresenius Kabi will deliver a treatment that will enable patients to remain on RAASi therapy by managing their chronic hyperkalemia... Nov 21
-Advertisements-